Metabolic Syndrome as a Risk Factor Among Lebanese Patients with Substance Use Disorder Undergoing Treatment for Recovery Through Rehabilitation or Opioid Substitution Treatment
2024

Metabolic Syndrome in Lebanese Patients with Substance Use Disorder

Sample size: 155 publication 10 minutes Evidence: moderate

Author Information

Author(s): Mahboub Nadine, Ayoub Elissa, Mounzer Carine, Baltagi Tatiana Kate, Papandreou Dimitrios, de Vries Nanne, Rizk Rana

Primary Institution: Lebanese International University

Hypothesis

The study aims to explore the extent of metabolic syndrome and its components among people with substance use disorder undergoing treatment in Lebanon.

Conclusion

Metabolic syndrome and its components are prevalent in people with substance use disorder undergoing treatment for recovery.

Supporting Evidence

  • 22.7% of the sample were diagnosed with metabolic syndrome.
  • 56.8% had low HDL-C and 51.6% had elevated blood pressure.
  • Higher age was associated with higher odds of being diagnosed with metabolic syndrome.

Takeaway

This study found that many people in Lebanon who are getting help for drug problems also have health issues related to metabolic syndrome, which can make them sick later.

Methodology

A cross-sectional study collecting demographic, treatment-related, nutritional, and biochemical data from participants.

Potential Biases

Potential bias due to the exclusion of females and reliance on self-reported data.

Limitations

The study did not include female participants and relied on self-reported data, which may introduce bias.

Participant Demographics

All participants were male, with a mean age of 32.53 years, and most had at least an intermediate level of education.

Statistical Information

P-Value

0.002

Confidence Interval

95% CI: 1.021–1.126

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3390/clinpract14060210

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication